Literature DB >> 7568629

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

J C Cole1, G J Burroughs, C R Laverty, N C Sheriff, E A Sparham, R J Rodgers.   

Abstract

The influence of alpha 2-adrenoceptor antagonists in animal models of anxiety is quite inconsistent, with results spanning the full range of effect from anxiogenesis to anxiolysis. In the present study, an ethological technique was used to examine the effects of yohimbine (0.5-4.0 mg/kg) on plus-maze behaviour in DBA/2 mice. Results indicated significant anxiolytic-like effects on standard spatiotemporal measures at 2.0-4.0 mg/kg, and on risk assessment measures across the entire dose range. Full-scale follow-up studies with T1 and BALB/c strains confirmed that this action of yohimbine in the murine plus-maze is not peculiar to DBA/2 mice. The more selective alpha 2-adrenoceptor antagonist, idazoxan (0.63-5.0 mg/kg), exerted much weaker behavioural effects in the maze while the alpha 2-adrenoceptor agonist, clonidine (0.01-0.1 mg/kg), produced a profile consistent with non-specific behavioural disruption. Data are discussed in relation to the possible involvement of 5-HT1A receptor mechanisms in the observed anxiolytic-like effects of yohimbine in the murine plus-maze.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568629     DOI: 10.1007/BF02245943

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

Review 1.  The contribution of behavioural studies to the neuropharmacology of anxiety.

Authors:  S E File
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

2.  Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs.

Authors:  J De Vry; U Benz; R Schreiber; J Traber
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

3.  Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm.

Authors:  M Davis; D E Redmond; J M Baraban
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

4.  B-HT 920 antagonizes rat neophobia in the X-maze test: a comparative study with other drugs active on adrenergic and dopaminergic receptors.

Authors:  F Ferrari; P L Tartoni; V Mangiafico
Journal:  Arch Int Pharmacodyn Ther       Date:  1989 Mar-Apr

5.  Does anxiety underly imidazole-induced behavioural effects in the rat?

Authors:  F Ferrari; P G Tartoni; A Monti; V Mangiafico
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Attenuation of the effects of ethanol on social behavior by alpha 2-adrenoceptor antagonists.

Authors:  M J Durcan; L A Hilakivi; R G Lister; M Linnoila
Journal:  Alcohol       Date:  1989 May-Jun       Impact factor: 2.405

7.  Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice.

Authors:  M J Durcan; R G Lister; M Linnoila
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Comparison of the effects of yohimbine and clonidine on the behaviour of female mice during social encounters in an "approach-avoidance" situation.

Authors:  M G Cutler
Journal:  Neuropharmacology       Date:  1993-05       Impact factor: 5.250

9.  Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions.

Authors:  M A Critchley; K Njung'e; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Noradrenergic function in panic disorder. Effects of intravenous clonidine pretreatment on lactate induced panic.

Authors:  J D Coplan; M R Liebowitz; J M Gorman; A J Fyer; D J Dillon; R B Campeas; S O Davies; J Martinez; D F Klein
Journal:  Biol Psychiatry       Date:  1992-01-15       Impact factor: 13.382

View more
  8 in total

1.  Differential behavioral responses of zebrafish larvae to yohimbine treatment.

Authors:  Qiang Li; Jia Lin; Yinglan Zhang; Xiuyun Liu; Xiao Qian Chen; Ming-Qing Xu; Lin He; Sheng Li; Ning Guo
Journal:  Psychopharmacology (Berl)       Date:  2014-06-25       Impact factor: 4.530

2.  The effect of alpha 2 adrenoceptor blockers on aggressive behavior in mice: implications for the actions of adrenoceptor agents.

Authors:  J Haller; G B Makara; J L Kovács
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

3.  Effects of antisense to the (alpha)2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behavior tests in sham-operated and castrated male rats.

Authors:  G T Shishkina; T S Kalinina; N Y Sournina; N N Dygalo
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

4.  Anxiety phenotype in mice that overexpress protein kinase A.

Authors:  Margaret F Keil; George Briassoulis; Nirmal Gokarn; Maria Nesterova; T John Wu; Constantine A Stratakis
Journal:  Psychoneuroendocrinology       Date:  2011-10-22       Impact factor: 4.905

5.  Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.

Authors:  Andrew Holmes; Rebecca J Yang; Jacqueline N Crawley
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

6.  Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.

Authors:  George Briassoulis; Margaret F Keil; Bilal Naved; Sophie Liu; Matthew F Starost; Maria Nesterova; Nirmal Gokarn; Anna Batistatos; T John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2016-03-16       Impact factor: 3.332

7.  Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

Authors:  N J Johnson; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 8.  Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine.

Authors:  Andrew Holmes; Gregory J Quirk
Journal:  Trends Pharmacol Sci       Date:  2009-12-28       Impact factor: 14.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.